- Case report
- Open Access
- Open Peer Review
Salmonella enterica serovar Virchow meningitis in a young man in Italy: a case report
© Lombardi et al.; licensee BioMed Central Ltd. 2014
- Received: 2 May 2013
- Accepted: 16 December 2013
- Published: 6 May 2014
Salmonella enterica is a leading cause of foodborne infections worldwide and includes more than 2500 different serovars, causing primarily gastroenteritis. However, the infection may occur elsewhere and produce characteristic clinical syndromes. Meningitis is a rare complication that occurs in less than 1% of clinical salmonellosis.
We describe a case of Salmonella Virchow meningitis in a 36-year-old Caucasian man presenting with headache in the occipital region, associated fever, nausea and vomiting, dyspnea and ambulatory difficulty. The cerebrospinal fluid culture showed growth of Salmonella, later confirmed to be Salmonella enterica serovar Virchow.
Salmonella Virchow infection is rare and this report highlights the risk of meningitis as a presentation of salmonellosis. To the best of our knowledge this is the first Italian case of meningitis due to Salmonella Virchow in a young adult. The probable route of transmission remains unclear and a long carriage state after a previous episode of gastroenteritis should be considered.
- Carrier state
- Salmonella Virchow
Salmonella enterica represents a leading cause of foodborne infections worldwide and includes more than 2500 different serovars, which primarily cause gastroenteritis. However, infection at other sites may occur, producing characteristic clinical syndromes. Meningitis is a rare complication which is diagnosed in less than 1% of clinical salmonellosis . In Italy, dedicated surveillance systems for invasive bacterial diseases  and for human gastrointestinal infections (ENTER-NET Italia)  have been active since 1994 and 1980, respectively. The two networks are coordinated by the Istituto Superiore di Sanità (ISS), Rome, Italy, in collaboration with the Regional Health Institutions.
In this paper, we describe the first Italian case of Salmonella Virchow meningitis in an adult. Meningitis was eventually related to a long carriage state after a previous episode of gastroenteritis and the case was detected by the two dedicated Italian surveillance systems.
A 36-year-old Caucasian man was admitted to hospital in November 2010 due to fever (38.5°C) associated with chills, occipital headache, nausea and vomiting but not diarrhea, neck pain, asthenia, dyspnea, slight neck stiffness and ambulatory difficulty. His cerebrospinal fluid (CSF) showed an elevated protein level (588mg/dL), glucose 31mg/dL and a white blood cell count of 3500/μL. On the basis of the clinical observation and laboratory findings, a provisional diagnosis of bacterial meningitis was made and empiric therapy of intravenous ceftriaxone and sulbactam/ampicillin was started before he was transferred to a different hospital specialized for infectious diseases.
He reported meningococcal ACWY vaccination in 2003 during his stay in Senegal, Africa. Hence, a clinical evaluation and microbiological investigations for Neisseria meningitidis and Haemophilus influenzae were performed. During the night his health condition improved, probably due to the antimicrobial therapy. On the following day, a diagnostic nested-polymerase chain reaction was performed on deoxyribonucleic acid (DNA) extracted from his CSF specimen , which excluded infection by N. meningitidis, H. influenzae, Streptococcus pneumoniae and Streptococcus agalactiae. In the meantime, the CSF culture showed growth of Salmonella, later confirmed to be Salmonella enterica serovar Virchow by the ISS reference laboratory. Culture from feces or blood was not performed because he was under treatment with antimicrobials.
An antimicrobial susceptibility test that was performed following guidelines by the National Committee for Clinical Laboratory Standards showed that the strain was susceptible to all antibiotics tested, (nalidixic acid, ampicillin, cefotaxime, chloramphenicol, gentamicin, kanamycin, streptomycin, sulphonamides, tetracycline, and trimethoprim–sulphamethoxazole) but showed a reduced susceptibility to ciprofloxacin (minimum inhibitory concentration >0.25μg/mL).
Past patient history revealed that in September 2010 he attended a wedding party in Spain where he ate raw fish. After 48 hours he developed gastroenteritis together with two other guests. He did not seek medical examination, and underwent self-treatment with antidiarrheal drugs and probiotics; no microbiological or epidemiological data are available. At the end of September he returned to Italy where he was admitted to a hospital emergency unit for the occurrence of an itchy papule, reporting a previous bronchopulmonary infection which was treated with ciprofloxacin and levofloxacin for 25 days. After 4 days he presented again to the hospital because of a persistent fever; pneumonia in the resolution phase was diagnosed and therapy with macrolides was started.
Antimicrobial intravenous therapy was continued (ampicillin/sulbactam and ceftriaxone) together with administration of anti-edema medications and steroids. The course was regular without any complication: he remained afebrile and his headache resolved slowly.
He was discharged home after 15 days in good condition. He was recommended to undergo additional tests to assess his immunologic status due to previous diagnosed deficit of CD4+ T lymphocytes and immunoglobulin M positivity for Cytomegalovirus but he declined to have further investigation.
Salmonella enterica serovar Virchow belongs to Group C and is rarely isolated from gastrointestinal infection, accounting for 0.1% to 0.5% in Italy and 0.8% in the European Union of all Salmonella serovars isolated from human cases ; it has been frequently isolated from contaminated vegetables, broiler, chicken, and the environments of slaughterhouses and layer farms worldwide . This serovar is considered a relevant public health problem by the European Community together and was reported in 0.7% of human cases in 2009 and 2010 . S. Virchow together with S. Typhimurium, S. Enteritidis, S. Hadar and S. Infantis has been included in the monitoring program as indicated in the zoonoses Directive 2003/99/CE as well as the control program for breeding, laying and broiler flocks of Gallus gallus (Regulation (EC) No 2160/2003). S. Virchow strains resistant both to amikacin and gentamicin, as well as to third generation cephalosporins  and with reduced susceptibility to fluoroquinolones , have been reported. The emergence of antimicrobial resistance is of particular concern because this serovar seems to show a predilection for extra-intestinal infection . Moreover, whereas non-typhoid Salmonella bacteremia is usually associated with a favorable outcome in children it can be life-threatening in adults .
In Italy, between 1997 and 2013, only six pediatric cases of meningitis due to Salmonella infection were reported, and none of these were of Group C (data from National Surveillance Systems for invasive bacterial diseases, ISS, Rome, Italy, unpublished data) ; hence, to the best of our knowledge, we here describe the first case in Italy of S. Virchow meningitis in an adult. A previous study in the United Kingdom reported that S. Virchow caused eight cases of bacteremia in adults; although none of the patients developed meningitis, all were secondary to gastroenteritis and two had a travel history in Spain . In addition, three cases of meningitis following S. Virchow food poisoning in adults were reported in the United Kingdom  and one case was documented in Scotland in an 18-year-old patient . Furthermore, two cases of meningitis caused by S. Virchow have been described in Sweden and in Germany [4, 15] which shared some features with the case in Italy in that both the patients travelled abroad (Thailand and Denmark, respectively), were not part of an outbreak and the source of infection remains unknown. However, for the Italian patient it is possible that the meningitis occurred after a foodborne infection 2 months prior to onset, and because antibiotic administration for other pathologies may have prolonged the intestinal carriage of the bacterium . The fact that the patient received a prolonged course of both ciprofloxacin and levofloxacin is likely to have contributed to the reduced susceptibility to ciprofloxacin of the strain. In addition, according to laboratory data and anamnesis, immunodepression of the patient could not be excluded, although further clinical information was not available and he did not report any underlying medical conditions.
This report further highlights the risk of meningitis as a presentation of salmonellosis and, to the best of our knowledge, describes the first case in Italy of S. Virchow meningitis in a young adult patient which was probably related to a long carriage state after a previous episode of gastroenteritis. Of interest, the infection was independently detected by the two Italian surveillance systems for invasive bacterial diseases and for human gastrointestinal infections (ENTER-NET Italia), providing additional evidence of the usefulness of dedicated surveillance systems. In fact, infection by S. Virchow is rare and the likely route of transmission remains unclear and requires further surveillance. Parry et al.  in a recent retrospective study showed that S. Virchow and Panama were more commonly associated with bacteremia and concluded that secondary bacteremia can be associated with an adverse outcome in non-human immunodeficiency virus (HIV)-infected adults admitted to hospital with non-typhoidal Salmonella gastroenteritis. Hence, antibiotic therapy can be considered in patients at high risk of secondary bacteremia, including elderly patients (>65 years) and younger adults with underlying chronic conditions.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We acknowledge the helpful comments from Dr Jim McLauchlin, Lead Public Health Microbiologist, Food Water and Environmental Microbiology Services - Public Health England (PHE), London, UK. We are grateful to the staff of the laboratories participating in ENTER-NET surveillance who referred the isolates of Salmonella to the ISS Laboratory of Enteric Pathogens, and to the group of Infectious Diseases of Hygiene Service and Public Health of ASL TO1 for collecting the medical and epidemiological information. This work was partially supported by a grant of the Italian Ministry of Health, Centro Nazionale per la Prevenzione ed il Controllo delle Malattie (CCM; project ‘Enter-net Italia, sorveglianza di laboratorio dei patogeni enterici trasmessi da alimenti e acqua: sviluppo delle attività dei laboratori di riferimento e di interventi di prevenzione (1M20-1097/2010)’).
The European Centre for Disease Prevention and Control has no responsibility for the views expressed in this article.
- Gille-Johnson P, Kövamees J, Lindgren V, Aufwerber E, Struve J: Salmonella Virchow meningitis in an adult. Scand J Infect Dis. 2000, 32: 431-433. 10.1080/003655400750045088.View ArticlePubMedGoogle Scholar
- Sistema Informatizzato Malattie Infettive. Weblink: “http://www.simi.iss.it/dati.htm” Accessed on April 2th, 2014
- ENTER-NET Italia. Weblink: “http://www.iss.it/ente/” Accessed on April 2th, 2014
- Hall LM, Duke B, Urwin G: An approach to the identification of the pathogens of bacterial meningitis by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis. 1995, 14: 1090-1094. 10.1007/BF01590946.View ArticlePubMedGoogle Scholar
- European Centre for Disease Prevention and Control: Annual epidemiological report on communicable diseases in Europe. 2009, StockholmGoogle Scholar
- Chu C, Doublet B, Lee YL, Cloeckaert A, Chiou CS, Chen SW, Lin CW, Chiu CH: Salmonella genomic island 1-J variants associated with change in the antibiotic resistance gene cluster in multidrug-resistant Salmonella enterica serovar Virchow isolated from humans, Taiwan, 2004–2006. Clin Microbiol Infect. 2012, 18: 47-53.View ArticlePubMedGoogle Scholar
- European Centre for Disease Prevention and Control: The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2010. EFSA Journal. 2012, 10 (3): 2597-Table SA30View ArticleGoogle Scholar
- Herrera-León S, González-Sanz R, Rodríguez I, Rodicio MR, Echeita MA: Spread of a multiresistant CTX-M-9-producing Salmonella enterica serotype Virchow phage type 19 in Spain. Eur J Clin Microbiol Infect Dis. 2010, 29: 901-905. 10.1007/s10096-010-0939-6.View ArticlePubMedGoogle Scholar
- Meakins S, Fisher IS, Berghold C, Gerner-Smidt P, Tschäpe H, Cormican M, Luzzi I, Schneider F, Wannett W, Coia J, Echeita A, Threlfall EJ, Enter-net participants: Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000–2004: a report from the Enter-net International Surveillance Network. Microb Drug Resist. 2008, 14: 31-35. 10.1089/mdr.2008.0777.View ArticlePubMedGoogle Scholar
- Lee SC, Yang PH, Shieh WB, Lasserre R: Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin Infect Dis. 1994, 19: 693-696. 10.1093/clinids/19.4.693.View ArticlePubMedGoogle Scholar
- Working group for invasive bacterial diseases surveillance: Meningitis and other invasive bacterial diseases surveillance in Italy Report 2005–2009. 2012, Roma, Italy: Rapporti ISTISAN, 1-43.Google Scholar
- Ispahani P, Slack RC: Enteric fever and other extraintestinal salmonellosis in University Hospital, Nottingham, UK, between 1980 and 1997. Eur J Clin Microbiol Infect Dis. 2000, 19: 679-687. 10.1007/s100960000341.View ArticlePubMedGoogle Scholar
- Norris PG: Meningism following Salmonella Virchow food poisoning. Postgrad Med J. 1986, 62: 621-622. 10.1136/pgmj.62.729.621.View ArticlePubMedPubMed CentralGoogle Scholar
- Todd WT, Murdoch JM: Salmonella Virchow: a cause of significant bloodstream invasion. Scott Med J. 1983, 28: 176-178.PubMedGoogle Scholar
- Eckerle I, Zimmermann S, Kapaun A, Junghanss T: Salmonella enterica serovar Virchow bacteremia presenting as typhoid-like illness in an immunocompetent patient. J Clin Microbiol. 2010, 48: 2643-2644. 10.1128/JCM.00217-10.View ArticlePubMedPubMed CentralGoogle Scholar
- Hohmann EL: Nontyphoidal salmonellosis. Clin Infect Dis. 2001, 32: 263-269. 10.1086/318457.View ArticlePubMedGoogle Scholar
- Parry CM, Thomas S, Aspinall EJ, Cooke RP, Rogerson SJ, Harries AD, Beeching NJ: A retrospective study of secondary bacteraemia in hospitalised adults with community acquired non-typhoidal Salmonella gastroenteritis. BMC Infect Dis. 2013, 27: 13-107.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.